Skip to Main Content

Author Details

Cheng Cheng
St. Jude Children's Research Hospital
2002
226
77
PMIDPaper TitleJournal TitlePublished Year
37408475Genomic analysis of venous thrombosis in children with acute lymphoblastic leukemia from diverse ancestries.Haematologica2024
36346962Coadministration of CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell Acute Lymphoblastic Leukemia: A Single-Arm, Multicenter, Phase II Trial.J Clin Oncol2023
37790080Effect of the tyrosine kinase inhibitors on the growth in children with Philadelphia chromosome-positive acute lymphoblastic leukemia: a case-control study.Lancet Reg Health West Pac2023
37729596Prognostic and Pharmacotypic Heterogeneity of Hyperdiploidy in Childhood ALL.J Clin Oncol2023
36798219Functional investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment.medRxiv2023
36352514Characterisation of children and adolescents with acute lymphoblastic leukaemia who presented without peripheral blood blasts at diagnosis.Br J Haematol2023
35084434Association of Genetic Ancestry With the Molecular Subtypes and Prognosis of Childhood Acute Lymphoblastic Leukemia.JAMA Oncol2022
35675514Impact of T-cell immunity on chemotherapy response in childhood acute lymphoblastic leukemia.Blood2022
35884569Genetic Polymorphisms Associated with Vincristine Pharmacokinetics and Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology Patients.Cancers (Basel)2022
36322880The Impact of Intensified CNS-Directed Therapy on Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated Without Cranial Irradiation.J Clin Oncol2022
36050548The genomic landscape of pediatric acute lymphoblastic leukemia.Nat Genet2022
36251744Clofarabine treatment of KMT2Ar infantile patients with acute lymphoblastic leukemia in St. Jude Total Therapy Study 16.Blood Adv2022
35151936Sub-myeloablative Second Transplantations with Haploidentical Donors and Post-Transplant Cyclophosphamide have limited Anti-Leukemic Effects in Pediatric Patients.Transplant Cell Ther2022
34875402Impact of High Disease Burden on Survival in Pediatric Patients with B-ALL Treated with Tisagenlecleucel.Transplant Cell Ther2022
33314235Contribution of donor- and recipient-associated factors to allergic transfusion reactions to platelets.Transfusion2021
33768542Class II Human Leukocyte Antigen Variants Associate With Risk of Pegaspargase Hypersensitivity.Clin Pharmacol Ther2021
33742760Identification of small molecules that mitigate vincristine-induced neurotoxicity while sensitizing leukemia cells to vincristine.Clin Transl Sci2021
33742153Outcomes of pediatric patients who relapse after first HCT for acute leukemia or MDS.Bone Marrow Transplant2021
33684941Prognostic factors for CNS control in children with acute lymphoblastic leukemia treated without cranial irradiation.Blood2021
33598942Phase 1 study of bendamustine in combination with clofarabine, etoposide, and dexamethasone in pediatric patients with relapsed or refractory hematologic malignancies.Cancer2021
33895809Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL.Blood2021
34410295Association of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic Leukemia.JAMA Oncol2021
34480120Outcomes of pediatric patients with therapy-related myeloid neoplasms.Bone Marrow Transplant2021
34250504Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy.Blood Cancer Discov2021
34148065Clinicopathologic and prognostic features of TdT-negative pediatric B-lymphoblastic leukemia.Mod Pathol2021
34263927Hemophagocytic lymphohistiocytosis-like toxicity (carHLH) after CD19-specific CAR T-cell therapy.Br J Haematol2021
34170389Pharmacodynamics of cerebrospinal fluid asparagine after asparaginase.Cancer Chemother Pharmacol2021
27820722A Multilevel Analysis of U.S. Hospital Patient Safety Culture Relationships With Perceptions of Voluntary Event Reporting.J Patient Saf2020
32027741Reduced-dose intensity therapy for pediatric lymphoblastic leukemia: long-term results of the Recife RELLA05 pilot study.Blood2020
31697823Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia.Blood2020
31944221Effect of Dasatinib vs Imatinib in the Treatment of Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.JAMA Oncol2020
31736198The association of mediastinal mass in the formation of thrombi in pediatric patients with non-lymphoblastic lymphomas.Pediatr Blood Cancer2020
33056981Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations.Nat Commun2020
33164984Pharmacogenomics of intracellular methotrexate polyglutamates in patients' leukemia cells in vivo.J Clin Invest2020
33163412Outcome of Acute Respiratory Failure Secondary to Engraftment in Children After Hematopoietic Stem Cell Transplant.Front Oncol2020
32711740Evaluation of Chest Radiographs of Children with Newly Diagnosed Acute Lymphoblastic Leukemia.J Pediatr2020
32793890Mutational landscape and patterns of clonal evolution in relapsed pediatric acute lymphoblastic leukemia.Blood Cancer Discov2020
32929484Experience using intravenous posaconazole in paediatric and young adult oncology patients.J Antimicrob Chemother2020
32618122Prospective randomized trial of interventions for vincristine-related neuropathic pain.Pediatr Blood Cancer2020
32750103Dosing-related saturation of toxicity and accelerated drug clearance with pegaspargase treatment.Blood2020
32470390Extensive Remodeling of the Immune Microenvironment in B Cell Acute Lymphoblastic Leukemia.Cancer Cell2020
32273588Autologous hematopoietic cell transplantation for the treatment of relapsed/refractory pediatric, adolescent, and young adult Hodgkin lymphoma: a single institutional experience.Bone Marrow Transplant2020
32207157Incidence of hip and knee osteonecrosis and their associations with bone mineral density in children with acute lymphoblastic leukaemia.Br J Haematol2020
31612640Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemia.Pediatr Blood Cancer2020
30643249PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia.Nat Genet2019
34691895Ecological principle meets cancer treatment: treating children with acute myeloid leukemia with low-dose chemotherapy.Natl Sci Rev2019
31657981Improved CNS Control of Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation: St Jude Total Therapy Study 16.J Clin Oncol2019
30206300Concordance between glucose-6-phosphate dehydrogenase (G6PD) genotype and phenotype and rasburicase use in patients with hematologic malignancies.Pharmacogenomics J2019
31413907Treatment response and outcome of children with T-cell acute lymphoblastic leukemia expressing the gamma-delta T-cell receptor.Oncoimmunology2019
31409674Hypertension is a modifiable risk factor for osteonecrosis in acute lymphoblastic leukemia.Blood2019
  • 1 - 50 of 226

Recommended Authors

Thai Hoa Tran
Universite de Montreal
Career Start Year 2013
Number of shared co-authors 14
Hiroko Tanaka
Tokyo Medical and Dental University
Career Start Year 2012
Number of shared co-authors 4
Maxime Caron
Centre Hospitalier Universitaire Sainte-Justine
Career Start Year 2010
Number of shared co-authors 1
Daniel Bottomly
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2009
Number of shared co-authors 4
Lara E Sucheston-Campbell
The Ohio State University
Career Start Year 2007
Number of shared co-authors 10
Pascal St-Onge
CHU Sainte-Justine Research Center
Career Start Year 2007
Number of shared co-authors 2
Simon Drouin
Centre Hospitalier Universitaire Sainte-Justine
Career Start Year 2005
Number of shared co-authors 1
Kouros Owzar
Duke University
Career Start Year 2005
Number of shared co-authors 10
Marlise R Luskin
Dana-Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 6
Jianhua Hu
Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences
Career Start Year 2004
Number of shared co-authors 3
Christopher C Porter
Emory University School of Medicine
Career Start Year 2003
Number of shared co-authors 6
Gregory D Jenkins
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 11
Jacqueline E Payton
Washington University School of Medicine.
Career Start Year 2001
Number of shared co-authors 11
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 7
Ru-Fang Yeh
Genentech Inc.
Career Start Year 1999
Number of shared co-authors 7
Kerby Shedden
University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 0
Todd A Alonzo
Keck School of Medicine, University of Southern California
Career Start Year 1999
Number of shared co-authors 31
David M Weinstock
Merck & Co.
Career Start Year 1998
Number of shared co-authors 7
Shashikant Kulkarni
Centene Center for Health Transformation, Centene Corporation
Career Start Year 1998
Number of shared co-authors 12
Shahrad Rod Rassekh
British Columbia Children's Hospital, The University of British Columbia
Career Start Year 1998
Number of shared co-authors 3
Markus Metzler
University Hospital Erlangen
Career Start Year 1998
Number of shared co-authors 5
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 1
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 5
Arndt Borkhardt
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Career Start Year 1992
Number of shared co-authors 9
Wei Xu
Princess Margaret Cancer Centre
Career Start Year 1991
Number of shared co-authors 8
Brent W Zanke
University of Toronto
Career Start Year 1987
Number of shared co-authors 3
Daniel Sinnett
Sainte-Justine University Hospital Research Center
Career Start Year 1986
Number of shared co-authors 11
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Career Start Year 1983
Number of shared co-authors 25
Brad H Pollock
University of California davis
Career Start Year 1983
Number of shared co-authors 6

Collaborators

Ching-Hon Pui
St. Jude Children's Research Hospital
Co-authored papers 138
Mary V Relling
Departments of Pharmaceutical Sciences.
Co-authored papers 110
William E Evans
Departments of Oncology. St. Jude Children's Research Hospital
Co-authored papers 86
Sima Jeha
St. Jude Children's Research Hospital
Co-authored papers 74
Charles G Mullighan
St Jude Children's Research Hospital
Co-authored papers 34
Stanley Pounds
St. Jude Children's Research Hospital.
Co-authored papers 31
Stephen P Hunger
Children's Hospital of Philadelphia
Co-authored papers 31
Mignon L Loh
University of Washington
Co-authored papers 27
Scott C Howard
College of Nursing
Co-authored papers 27
Meenakshi Devidas
St Jude Children's Research Hospital
Co-authored papers 26
Kristine R Crews
St. Jude Children's Research Hospital
Co-authored papers 22
Jinghui Zhang
Changhai Hospital, Second Military Medical University
Co-authored papers 18
Yongjin Li
Mayo Clinic
Co-authored papers 15
Kathryn G Roberts
St Jude Children's Research Hospital
Co-authored papers 15
Melissa M Hudson
St Jude Children's Research Hospital
Co-authored papers 14
Geoffrey Neale
St. Jude Children's Research Hospital
Co-authored papers 13
Xueyuan Cao
University of Chinese Academy of Sciences
Co-authored papers 12
Michael Rusch
St Jude Children's Research Hospital
Co-authored papers 11
John Easton
St Jude Children's Research Hospital
Co-authored papers 11
Yu Liu
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital
Co-authored papers 11
Elaine R Mardis
The Ohio State University
Co-authored papers 10
Paul L Martin
Duke University Medical Center
Co-authored papers 9
Xin Zhou
St. Jude Children's Research Hospital
Co-authored papers 9
Robert S Fulton
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 9
Julie M Gastier-Foster
Baylor College of Medicine
Co-authored papers 8
Guolian Kang
Co-authored papers 7
Xiaotu Ma
St. Jude Children's Research Hospital
Co-authored papers 7
Chunxu Qu
Co-authored papers 7
Paul Scheet
University of Texas M.D. Anderson Cancer Center
Co-authored papers 7
Kim E Nichols
St. Jude Children's Research Hospital
Co-authored papers 6
Release 1.2